Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular Carcinoma

Clinical trial NCT04310709 · COMPLETED

Trial details

NCT number: NCT04310709
Sponsor: Asan Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular Hepatoma

Start date: 2020-06-16
Primary completion: 2022-05-30
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.